These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 3276544)
61. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF]. Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058 [TBL] [Abstract][Full Text] [Related]
62. Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia. Auber ML; Horwitz LJ; Blaauw A; Khorana S; Tucker S; Woods T; Warmuth M; Dicke KA; McCredie KB; Spitzer G Blood; 1988 Jan; 71(1):166-72. PubMed ID: 2446678 [TBL] [Abstract][Full Text] [Related]
63. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays. Jones RJ; Colvin OM; Sensenbrenner LL Cancer Res; 1988 Jun; 48(12):3394-7. PubMed ID: 3285994 [TBL] [Abstract][Full Text] [Related]
64. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574 [TBL] [Abstract][Full Text] [Related]
65. Comparative effects of amifostine (Ethyol) on normal hematopoietic stem cells versus human leukemic cells during ex vivo purging in autologous bone marrow transplants. Douay L; Hu C; Giarratana MC; Gorin NC Semin Oncol; 1994 Oct; 21(5 Suppl 11):16-20. PubMed ID: 7973773 [TBL] [Abstract][Full Text] [Related]
66. Cell-cycle disruptions and apoptosis induced by the cyclophosphamide derivative mafosfamide. Davidoff AN; Mendelow BV Exp Hematol; 1993 Jul; 21(7):922-7. PubMed ID: 8319782 [TBL] [Abstract][Full Text] [Related]
67. A simple method to detect immature hemopoietic progenitors after in vitro treatment with ASTA-Z 7654. Lamana M; Gonzalez R; Camara R; Steegmann JL; Fernandez-Rañada JM Prog Clin Biol Res; 1992; 377():35-9. PubMed ID: 1438430 [No Abstract] [Full Text] [Related]
68. Activated lymphocytes in the marrow cell suspension decrease the mafosfamide-induced CFU-GM cytotoxicity. Woźny T; Sawiński K; Kozłowska-Skrzypczak M; Hansz J Acta Haematol Pol; 1995; 26(4):367-75. PubMed ID: 8571738 [TBL] [Abstract][Full Text] [Related]
69. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V; Ferguson KF; Heller G; Kernan NA Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927 [TBL] [Abstract][Full Text] [Related]
70. Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy. de Haan G; Engel C; Dontje B; Loeffler M; Nijhof W Cancer Res; 1995 Jan; 55(2):324-9. PubMed ID: 7529132 [TBL] [Abstract][Full Text] [Related]
72. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM; Gulati SC Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721 [TBL] [Abstract][Full Text] [Related]
73. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts. Yamazaki T; Sato Y; Sieber F Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739 [TBL] [Abstract][Full Text] [Related]
74. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation. Novitzky N; Mohamed R Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962 [TBL] [Abstract][Full Text] [Related]
75. Etoposide with/without G-CSF with busulfan and cyclophosphamide as conditioning for bone marrow transplantation. The BMT Team. Kanda Y; Akiyama H; Tanikawa S; Sakamaki H; Sasaki T; Takamoto S; Onozawa Y Am J Hematol; 1996 Apr; 51(4):265-8. PubMed ID: 8602625 [TBL] [Abstract][Full Text] [Related]
76. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Maestroni GJ; Covacci V; Conti A Cancer Res; 1994 May; 54(9):2429-32. PubMed ID: 8162592 [TBL] [Abstract][Full Text] [Related]
77. Increased efficacy in selective elimination of leukemic cell line clonogenic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosfamid (ASTA Z 7557). LeBien TW; Anderson JM; Vallera DA; Uckun FM Leuk Res; 1986; 10(2):139-43. PubMed ID: 3951251 [TBL] [Abstract][Full Text] [Related]
78. No preferential sensitivity of clonogenic AML cells to ASTA-Z-7557. Kluin-Nelemans HC; Martens AC; Löwenberg B; Hagenbeek A Leuk Res; 1984; 8(4):723-8. PubMed ID: 6590937 [TBL] [Abstract][Full Text] [Related]
79. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial. Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281 [TBL] [Abstract][Full Text] [Related]
80. Growth of hemopoietic cells after incubation with VP 16-213. Schulze E; Hofmann U; Woetzel M; Helbig W Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):591-6. PubMed ID: 2480314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]